Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leurs

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|February 2, 1970
[Reverse mutants of lambda prophage defective for chi segment]P Brachet, C Leurs, P Barrand, et al.
Nucleic Acids Research|May 18, 2005
Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA libraryZ Li, J Stanelle, C Leurs, et al.
RNA (New York, N.Y.)|May 3, 2001
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNAS Kammler, C Leurs, M Freund, et al.
European Journal of Neurology|March 29, 2016
High cumulative JC virus seroconversion rate during long-term use of natalizumabA Vennegoor, J A van Rossum, C Leurs, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|February 2, 1970
[Reverse mutants of lambda prophage defective for chi segment]P Brachet, C Leurs, P Barrand, et al.
Nucleic Acids Research|May 18, 2005
Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA libraryZ Li, J Stanelle, C Leurs, et al.
RNA (New York, N.Y.)|May 3, 2001
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNAS Kammler, C Leurs, M Freund, et al.
European Journal of Neurology|March 29, 2016
High cumulative JC virus seroconversion rate during long-term use of natalizumabA Vennegoor, J A van Rossum, C Leurs, et al.
Pageof 1